Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen-mediated attenuation of stemness.

已完结 10 由给力认识发布于 2026/9/9 21:37:34

DOI:10.1097/CAD.0000000000001311
作者：Zhe Lu,?Zhuo Zhang,?Min Yang,?Meifang Xiao
文献类型：期刊论文
补充材料：只需要正文

Wolters Kluwer Ovid

Abstract：Currently, resistance to the chemotherapeutic agent doxorubicin (Dox) in hepatocellular carcinoma (HCC) cells is an obstacle in developing effective Dox-targeted clinical therapies. Ubiquiti

应助信息

2小时前

亮露

0b3c98d2ac5511f1a43834735aa3bc31.pdf 已采纳

2小时前

Book学术机器人

2026/9/9 21:37:34 未找到该文献，机器人已退出，请等待人工下载

2026/9/9 21:37:34 Book学术AI机器人收到请求，开始寻找文献

2026/9/9 21:37:34 已向机器人发送请求

2小时前

给力认识发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierUnraveling the structural and dynamic heterogeneities of hydroxyl-functionalized di-cationic ionic liquids (HFDILs): An integrated ab initio and molecular dynamics approach